摘要
纳米晶技术作为过去20年里国际公认最成功的纳米药物递送系统之一，也是过去整个药剂学研究中最具竞争力的高端制剂代表。毕竟就过去而言，新化合物的溶解度差一直是困扰新药研发的主要因素之一。而纳米晶技术的出现，被认为是最切实有效的减小药物粒径的方法。减小粒径的又正好是提高化合物溶解度最好的方法，因此纳米尺度和晶型技术上的共同开发在制药行业也因此爆发出广阔的应用前景，并逐渐应用于包括医药研发在内的大多数工业生产。
关键词： 右纳米晶注射给药；生物药剂学研究
Abstract
Nanocrystalline technology, as one of the most successful nanomedicine delivery systems internationally recognized in the past 20 years, is also the most competitive representative of high-end preparations in the entire pharmaceutical research in the past. After all, in the past, the poor solubility of new compounds has been one of the main factors that have plagued the development of new drugs. The emergence of nanocrystalline technology is considered to be the most practical and effective method to reduce drug particle size. Reducing the particle size is just the best way to improve the solubility of compounds, so the joint development of nanoscale and crystal technology has a broad application prospect in the pharmaceutical industry, and is gradually used in most industrial production, including pharmaceutical research and development.
Key words： Right nanocrystalline injection; Biopharmaceutical research
参考文献 References
[1] 颜蓉,王亚男,许来,等.纳米晶作为眼部药物递送系统的研究进展[J].中国药学杂志,2020,55(24):117-118.
[2] 吴帅聪,秦超,韩晓鹏,等.药物纳米晶的制备及其口服转运机制研究进展[J].药学进展,2023,23(19):45-55.
[3] 赵鹏飞,李慧霞,甘丹,等.羟基喜树碱纳米晶制备及药剂学性质研究[J].中国医院药学杂志,2021,31(23):41-47.
[4] 金鹤翔,屠露萍,饶泽鹏,等.纳米晶注射给药的生物药剂学研究进展[J].中国新药杂志,2023,32(20):2066-2072.
[5] 王若楠,袁鹏辉,杨德智,等.纳米晶药物的应用及展望[J].医药导报,2020,39(08):71-75.
[6] 王荣荣,孙文军,刘江伟,等.姜黄素纳米晶注射液的制备及体内外性质评价[J].中国药科大学学报,2022,53(01): 188-189.
[7] 丁静雯、王君吉、何军.影响注射用长效纳米晶混悬型注射液体内外释药因素的概述[J].中国医药工业杂志,2020, 51(12):121-122.
[8] 冯锁民,赵子齐,张佳欣,等.泡腾沉淀法制备呋塞米纳米晶的工艺及药剂学特性[J].化工科技,2023,31(02):34-39.